Suivre
Houda Bahig
Houda Bahig
Centre Hospitalier de l'Universite de Montreal
Adresse e-mail validée de ssss.gouv.qc.ca
Titre
Citée par
Citée par
Année
Spatially fractionated radiation therapy: History, present and the future
W Yan, MK Khan, X Wu, CB Simone II, J Fan, E Gressen, X Zhang, ...
Clinical and translational radiation oncology 20, 30-38, 2020
1092020
SUNSET: Stereotactic radiation for ultracentral non–small-cell lung cancer—A safety and efficacy trial
M Giuliani, AS Mathew, H Bahig, SV Bratman, E Filion, D Glick, AV Louie, ...
Clinical lung cancer 19 (4), e529-e532, 2018
1012018
Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease
H Bahig, E Filion, T Vu, J Chalaoui, L Lambert, D Roberge, M Gagnon, ...
Practical radiation oncology 6 (5), 367-374, 2016
962016
Predictive parameters of CyberKnife fiducial-less (XSight Lung) applicability for treatment of early non-small cell lung cancer: a single-center experience
H Bahig, MP Campeau, T Vu, R Doucet, DB Nadeau, B Fortin, D Roberge, ...
International Journal of Radiation Oncology* Biology* Physics 87 (3), 583-589, 2013
862013
Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial
AC Nichols, P Lang, E Prisman, E Berthelet, E Tran, S Hamilton, J Wu, ...
BMC cancer 20, 1-13, 2020
652020
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell lung cancer: A real …
A Desilets, F Blanc-Durand, S Lau, T Hakozaki, R Kitadai, J Malo, ...
European Journal of Cancer 142, 83-91, 2021
582021
Neutrophil count is associated with survival in localized prostate cancer
H Bahig, D Taussky, G Delouya, A Nadiri, A Gagnon-Jacques, ...
BMC cancer 15, 1-8, 2015
552015
Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma
H Bahig, F Aubin, J Stagg, O Gologan, O Ballivy, E Bissada, ...
BMC cancer 19, 1-15, 2019
502019
Magnetic resonance-based response assessment and dose adaptation in human papilloma virus positive tumors of the oropharynx treated with radiotherapy (MR-ADAPTOR): an R-IDEAL …
H Bahig, Y Yuan, ASR Mohamed, KK Brock, SP Ng, J Wang, Y Ding, ...
Clinical and translational radiation oncology 13, 19-23, 2018
502018
The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review
M Tonneau, A Elkrief, D Pasquier, TP Del Socorro, M Chamaillard, ...
Radiotherapy and Oncology 156, 1-9, 2021
492021
Hypofractionated radiation therapy for breast ductal carcinoma in situ
L Hathout, T Hijal, V Théberge, B Fortin, H Vulpe, JC Hogue, C Lambert, ...
International Journal of Radiation Oncology* Biology* Physics 87 (5), 1058-1063, 2013
482013
Dual-energy computed tomography for prediction of loco-regional recurrence after radiotherapy in larynx and hypopharynx squamous cell carcinoma
H Bahig, A Lapointe, S Bedwani, J de Guise, L Lambert, E Filion, ...
European journal of radiology 110, 1-6, 2019
412019
Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy
SP Ng, C Pollard III, J Berends, Z Ayoub, M Kamal, AS Garden, H Bahig, ...
Cancer 125 (11), 1823-1829, 2019
382019
Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy
SP Ng, C Pollard III, M Kamal, Z Ayoub, AS Garden, H Bahig, GB Gunn, ...
NPJ Precision Oncology 3 (1), 22, 2019
372019
Predictive factors of survival and treatment tolerance in older patients treated with chemotherapy and radiotherapy for locally advanced head and neck cancer
H Bahig, B Fortin, M Alizadeh, L Lambert, E Filion, L Guertin, T Ayad, ...
Oral oncology 51 (5), 521-528, 2015
362015
Excellent cancer outcomes following patient-adapted robotic lung SBRT but a case for caution in idiopathic pulmonary fibrosis
H Bahig, E Filion, T Vu, D Roberge, L Lambert, M Bouchard, C Lavoie, ...
Technology in cancer research & treatment 14 (6), 667-676, 2015
352015
Predicting 5-year progression and survival outcomes for early stage non-small cell lung cancer treated with stereotactic ablative radiation therapy: development and validation …
J Kang, MS Ning, H Feng, H Li, H Bahig, ED Brooks, JW Welsh, R Ye, ...
International Journal of Radiation Oncology* Biology* Physics 106 (1), 90-99, 2020
312020
Assessing lung function using contrast‐enhanced dual‐energy computed tomography for potential applications in radiation therapy
A Lapointe, H Bahig, D Blais, H Bouchard, É Filion, JF Carrier, S Bedwani
Medical physics 44 (10), 5260-5269, 2017
312017
Agreement among RTOG sarcoma radiation oncologists in contouring suspicious peritumoral edema for preoperative radiation therapy of soft tissue sarcoma of the extremity
H Bahig, D Roberge, W Bosch, W Levin, I Petersen, M Haddock, ...
International Journal of Radiation Oncology* Biology* Physics 86 (2), 298-303, 2013
302013
A study of pseudoprogression after spine stereotactic body radiation therapy
H Bahig, D Simard, L Létourneau, P Wong, D Roberge, E Filion, D Donath, ...
International Journal of Radiation Oncology* Biology* Physics 96 (4), 848-856, 2016
292016
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20